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Abstract 
Three different pyrene derivatives, pyrene decanoyi phosphatidylcholine (PIoPC), pyrene dodecanoyl sulfatide (PI2CS) and cholesteryl 
pyrenyl hexanoate (P6Chol), were used to follow lipid peroxidation i  low and high density lipoproteins. Probe-labelled lipoproteins were 
subjected to Cu 2+ catalyzed peroxidation. In all cases the fluorescence of the probes progressively decreased ue to the involvement of 
pyrene in the peroxidative reaction. Thus, we used the fluorescence decrease of P6Chol to monitor the lipid peroxidation in the 
hydrophobic core of LDL and HDL, and that of the amphipatic probes, PIoPC and P12CS, to follow lipid peroxidation i the envelope of 
both lipoproteins. The possibility of following lipid peroxidation i  individual lipoprotein regions could lead to more detailed information 
on the oxidative modifications that play an important role in the altered cholesterol homeostasis involved in the formation of 
atherosclerotic lesions. No differences were observed in the peroxidation kinetics of the hydrophobic ore of HDL and LDL monitored 
with P6Chol. On the contrary kinetics obtained with PloPC and P~2CS demonstrated the HDL envelope to be more susceptible to 
Cu2+-dependent lipid peroxidation than that of the LDL. This could be due to a greater adical generating capacity of the HDL envelope 
and can be explained on the basis of low vitamin E levels and large amounts of polyunsaturated fatty acids esterified on phospholipids 
determined in HDL, and on literature vidence that indicates HDL as the principal vehicle of circulating plasma lipid peroxides. 
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1. Introduction 
The peroxidation of low density lipoprotein (LDL) and 
the uptake of oxidized LDL by macrophages, via 
'scavenger' receptors whose expression is not regulated by 
cellular cholesterol levels, have been implicated in the 
formation of lipid laden cells [1]. This is an early and 
important step in the development of atherosclerotic le- 
sions [2,3]. Recent data indicate that not only does oxi- 
dized LDL actually exist in vivo [4-7] but it is also present 
in arterial atherosclerotic plaques [8]. 
In atherogenic processes the protective role of high 
density lipoproteins (HDL) is supported by the fact that 
plasma HDL levels have an inverse epidemiological corre- 
lation with the incidence of coronary artery disease [9]. 
The biochemical mechanisms of action of HDL in prevent- 
ing the development of atherosclerotic lesions are not well 
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established: nevertheless, experimental evidence supports 
that: (1) HDL serves as an acceptor of cholesterol effiux 
from foam cells (the cholesterol ester laden macrophages 
formed in atherosclerotic lesions) by a mechanism similar 
to that of 'reverse cholesterol transport' [10]; (2) oxidized 
phospholipids and lipid peroxidation products are rapidly 
exchanged between LDL and HDL [11,12]; (3) binding of 
transition metals by ApoAI inhibits the oxidation of LDL 
[13]. 
The presence of a specific binding protein for HDL, 
i.e., the HDL receptor, has been demonstrated in several 
cells such as parenchymal liver cells [14], sinusoidal liver 
cells [15], cells from steroidogenic tissues [16-18] and 
macrophages [19]. The mechanism hypothesized for 
HDL-dependent cholesterol efflux from macrophages i
based on a receptor-mediated non-lysosomal endocytic- 
exocytic pathway for HDL [20-22]. Although there is still 
no evidence of the existence of oxidatively modified HDL 
in vivo, it was recently demonstrated that the in vitro 
oxidation of HDL significantly reduces the capacity of the 
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lipoprotein to enhance cholesterol efflux from 
macrophage-derived foam cells [23]. This could depend on 
a reduced receptor affinity of oxidized HDL, as a conse- 
quence of ApoAI modification [24]. Endocytosis of modi- 
fied HDL seems to be mediated by a 'scavenger' receptor: 
the internalized particle is thought o be degraded in the 
lysosomal district but not addressed to the retroendocytotic 
pathway [25]. 
Lipid peroxidation can occur in both the envelope and 
the core of plasma lipoproteins. Thus the possibility of 
following the lipid peroxidation of the individual regions 
of LDL and HDL (i.e., core and surface) could lead to 
more detailed information on the modifications brought 
about by oxidation, modifications that are the basis of the 
altered cholesterol homeostasis nvolved in the formation 
of atherosclerotic lesions. 
We used three different pyrene derivatives, pyrene de- 
canoyl phosphatidylcholine (P~0PC), pyrene dodecanoyl 
sulfatide (PnCS) and cholesteryl pyrenyl hexanoate 
(P6Chol), to selectively follow the kinetics of Cu 2÷ cat- 
alyzed peroxidation at the surface and core of human LDL 
and HDL. Pyrene was chosen as the 'peroxidation-sensitive 
fluorophore' on the basis of previous studies [26] that 
demonstrated that the decrease in pyrene fluorescence, due 
to lipid peroxidation, strongly depends on the membrane 
region in which the probe is located. 
2. Materials and methods 
Analytical grade chemicals, distilled solvents and dou- 
bly distilled water were used. Egg phosphatidylcholine, 
/3-(pyren-l-yl) decanoyl y-palmitoyl L-C~ phosphatidyl- 
choline (P10PC), cholesteryl (pyren-l-yl) hexanoate 
(P6Chol) were purchased from Sigma Chemicals, 12-(1- 
pyrene) dodecanoic acid from Molecular Probes. This last 
was purified on a C18 reverse phase HPLC column [27]. 
N-(12-(- 1-pyrene) dodecanoyl) galactosylsphingosine 13_
sulfate (P~2CS) was prepared from galactosylsphingosine 
I3-sulfate following the procedure of Marchesini et al. [28]. 
2.1. Labelling of  lipoproteins with fluorescent probes 
Plasma was prepared from freshly obtained heparinized 
blood of overnight (o.n.) fasted, healthy and normo- 
lipidemic male and female subjects (30-40 years old). The 
fluorescent probes were incorporated into the lipoproteins 
by incubating the plasma for 60 min at 25°C in the 
presence of PIoPC, P12CS or P6Chol. In the case of PIoPC 
and P12CS, each was dissolved in 154 mM NaC1 and 
added to plasma to a final concentration of I0 nmol/ml; 
P6Chol was mixed with egg phosphatidylcholine (1:10 
mol: mol) and dissolved in 154 mM NaC1 then added to 
plasma to a final fluorescent lipid concentration of 20 
nmol/ml. 
LDL and HDL were prepared from plasma, with or 
without fluorescent probes, by ultracentrifugation using a 
multistep discontinuous gradient in a Beckman TL-100 
tabletop ultracentrifuge, adapting the conditions described 
by Havel et al. [29]. After separation LDL and HDL were 
dialyzed against 154 mM NaCI at 4°C for 12 h in order to 
eliminate KBr. Isolated and dialyzed lipoproteins were 
stored under argon gas in the dark at 4°C for a maximum 
of 2 weeks. 
2.2. Lipoprotein characterization 
The protein concentration of each lipoprotein fraction 
was determined with the Lowry method [30] using bovine 
serum albumin as standard. 
Total lipids were extracted from each lipoprotein frac- 
tion following the Folch procedure [31]. The phospholipid 
content was determined according to Bartlett [32]; choles- 
terol was determined using a reagent kit from Boehringer 
Mannheim. 
Pyrene lipids incorporated in LDL and HDL were ana- 
lyzed by TLC using 20 × 20 silica gel 60 plates (Merck). 
TLC plates were developed using a monodimensional dou- 
ble solvent technique; solvents used were: (A) 
CHC13:CH3OH:H20 (65:25:4 by vol.) and (B) CH3(CH 2) 
4CH3: (C2, H 5) 20: CH3COOH (70:30:1 by vol.). Plates 
developed with solvent A for 7 cm, were then dried and 
submitted to a second 15-cm long run in the same direc- 
tion using solvent B as developing system. P6Chol, P~0PC 
and PI2CS were used as standard lipids. 
Lipoprotein eutral ipids were extracted with 50 vol- 
umes of hexane after addition of 10 volumes of methanol 
to the lipoprotein fraction; chloroform was then added to 
the water/methanol phase for the Folch extraction of 
phospholipids. Fatty acid composition of neutral lipids and 
phospholipids was determined after methylation of the 
lipid extracts; the methylation was carried out in 0.5 M 
HC1 in degassed methanol at 80°C for 20 h. Fatty acid 
methyl esters were then extracted in hexane, the hexane 
phase was dried under nitrogen and fatty acid methyl 
esters resuspended in small volumes of hexane; a DANI 
HR PTV-2CH (flame ionization detector) connected with a 
3390 Hewlett Packard integrator was used. The analysis 
was performed by injecting 2 /xl of the sample into a 30 
meter Supelcowax 10 polar capillary column. The tempera- 
ture was maintained at 100°C for 3 min, then increased 
30°C/min up to 180°C then 3°C/min up to 260°C, this 
was followed by an isotherm step of 10 min. 
Vitamin E was extracted following the Vuilleumier 
method [33]. The amount of a-tocopherol of LDL and 
HDL was determined by HPLC using a Beckman system 
Gold 156 apparatus with a 4.6 mm ID × 100 mm column 
packed with 5 /zm LiChrospher RPI 8 (Merck, Darmstadt, 
Germany) protected by a 4 mm ID ×4 mm (5 /zm) 
LiChrospher RP18 Merck. The operating conditions were: 
methanol: acetonitrile (8:2 v:v), isocratic, 1.5 ml/min, 
spectrophotometric detection at 292 nm. 
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2.3. Lipoprotein peroxidation 
Peroxidation of LDL and HDL was induced by incubat- 
ing lipoproteins (0.1 mg protein/ml) suspended in 10 mM 
Tris-HC1, 154 mM NaC1 (pH 7.4) at 37°C with different 
concentrations (0.5-20 /xM) of copper sulfate. 
The oxidation of LDL and HDL was monitored by 
measuring the thiobarbituric acid reactive substances 
(TBARS) following the procedure of Buege and Aust [34]. 
The oxidation of labelled LDL and HDL was monitored 
by the decrease in the pyrene's fluorescence mission 
intensity at 379 nm (excitation 343 nm) [26]. This decrease 
was expressed as ((Fo-Ft)/F o) × 100, where F o represents 
the fluorescence intensity at zero time of peroxidation and 
F t the residual fluorescence for a given peroxidation time. 
The fluorimetrically determined peroxidation profile of 
each lipoprotein sample can be divided into latency, propa- 
gation and steady state phases and allows the evaluation of 
lag time, expressed in minutes, calculated as the intercept 
of the linear least square regression of the propagation 
phase with that of the latency phase. 
2.4. Excimer to monomer atio determinations 
Unlabeled LDL and HDL, (0.1 mg of protein) resus- 
pended in 10 mM Tris-HCl 154 mM NaC1 (pH 7.4) were 
incubated separately for 60 min at 25°C with PIoPC, and 
P12CS (5% of endogenous phospholipids). The Excimer 
(475 nm) to Monomer (379 nm) fluorescence intensity 
ratio of fluorescent lipids was evaluated as a function of 
temperature. 
The intensity of excimer fluorescence depends on the 
possibility of collisions between pyrene lipids. Thus, when 
the concentration of pyrene lipids in two different lipid 
structures i the same, the difference observed in the E /M 
vs temperature curves will indicate a different lateral mo- 
bility of the pyrene derivative in the lipid environment 
considered [35]. 
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Fig. 1. Distribution of pyrene derivatives of cholesterol, phosphatidyl- 
choline and sulfatide in LDL (striped bar) and HDL (open bar). Data are 
expressed as nmol/ml plasma. Measurements were done in triplicate on 
five donors. Data are means + S.D. (p = 5). 
different distribution in the lipoprotein fractions (Fig. 1): 
the amount of P6Chol found in LDL is 3-fold that in HDL; 
PIoPC is almost equally distributed between LDL and 
HDL; P12CS is preferentially incorporated in HDL, the 
amount being 4-fold that in LDL. Thin-layer chromatog- 
raphy of the LDL and HDL lipid extracts excluded the 
presence of fluorescent compounds other than those used 
for the lipoprotein labelling (data not shown). 
The distribution of P6Chol and P10PC mimicked that of 
corresponding natural compounds (Fig. 2). No comparison 
can be made of the preferential incorporation of P~2CS in 
HDL since the plasma of healthy subjects shows only 
traces of the corresponding atural compound sulfatide. On 
the basis of their distribution in different lipoproteins and 
2.5. Fluorescence measurements 
All fluorescence measurements were carried out in a 
Jasco spectrophotofluorimeter FP-777 equipped with a cu- 
vette holder. The temperature maintained by a Haake GD3 
thermostatic circulating bath, was monitored with a Sub- 
line PT 100 digital thermometer. 
2.6. Statistics 
The results were statistically evaluated by Student's 
t-test. 
3. Results 
The incubation of plasma with pyrene derivatives of 
cholesterol, phosphatidylcholine and sulfatide leads to their 
T~ 
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Fig. 2. Distribution of cholesterol and phospholipids in LDL (striped bar) 
and HDL (open bar). Data are expressed as /xmol/ml plasma. Measure- 
ments were done in triplicate on five donors. Data are means + S.D. 
(n = 5). 
P. Viani et al. /Biochimica et Biophysica Acta 1315 (1996) 78-86 81 
their chemical structure, it can be assumed that PIoPC and 
P12CS are located in the stabilizing 'envelope' (a mono- 
layer composed of specific apoproteins, phospholipids and 
unesterified cholesterol), and P6Chol in the cholesteryl 
ester and triglyceride-rich 'core' of lipoproteins. Thus 
amphipatic probes PI0PC and P12CS were used for moni- 
toring the kinetics of Cu2+-dependent lipid peroxidation i
the envelope and P6Chol for monitoring Cu2---dependent 
lipid peroxidation i the core of lipoprotein. 
The sensitivity of the pyrene ring to Cu2+-dependent 
lipid peroxidation was demonstrated by the absorption and 
emission spectra of pyrene recorded on the lipid extracts of 
HDL labelled with P~2CS. These spectra recorded before 
and after 40 min of lipid peroxidation clearly indicate (Fig. 
3) a 30% reduction in fluorescence emission and a parallel 
strong modification of the absorption spectra of pyrene. 
The time-dependent TBARS production in LDL and 
HDL is reported in Fig. 4A. After a latency phase of 40 
min, the TBARS production in LDL linearly increases up 
to about 180 rain, reaching a steady-state l vel with a 
maximal TBARS production of about 80 nmol/mg pro- 
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Fig. 3. Absorption (panel A) and emission (panel B) spectra of Pt2CS in 
HDL lipid extract before (unbroken line) and after (dotted line) 40 min 
Cu2+-dependent lipid peroxidation. 
tein. In HDL after a latency phase of 13 min the TBARS 
production linearly increases up to about 60 min with a 
maximal TBARS production of about 50 nmol/mg pro- 
tein. 
Incubation of P6Chol labelled LDL and HDL with 10 
/zM CuSO 4 determined, after a latency phase of 50 and 45 
rain (lag time) respectively, a progressive decrease in 
fluorescence mission intensity consequent to lipid per- 
oxidation (Fig. 4B). The kinetic profiles obtained with 
labelled LDL and HDL were very similar: in fact the 
latency phase was followed in both cases by a rapid linear 
increase in lipid peroxidation up to 120 min, and a steady- 
state phase monitored up to 300 min. Peroxidation profiles 
obtained incubating PIoPC labelled LDL and HDL with 10 
/zM CuSO 4 are reported in Fig. 4C. Kinetics of lipid 
peroxidation followed with PIoPC in the envelope of HDL 
and LDL were very different. After a latency phase of 20 
min, HDLs were rapidly peroxidized: a 70-80% decrease 
of pyrene fluorescence was reached after 60 min of incuba- 
tion. Also in these cases the rapid linear increase of lipid 
peroxidation was followed by a steady-state phase moni- 
tored up to 300 rain. On the contrary, when PIoPC was 
used to follow the oxidation of the LDL envelope, a lag 
time of about 60 rain was observed, the rate of lipid 
peroxidation after the latency phase being smaller than that 
observed in HDL labelled with the same probe; in fact a 
60% reduction of fluorescence was reached only after 300 
min of incubation. The kinetics obtained with Pj0PC in 
both LDL and HDL were confirmed by the data obtained 
with a different amphipatic probe, P~2CS (Fig. 4D). 
The lateral mobility of PtoPC and P~2CS in the enve- 
lope of LDL and HDL was evaluated by determining the 
excimer to monomer atio (E/M) as a function of the 
temperature after incorporation of equal amounts of the 
two probes (5 mol% of total phospholipids) in unlabelled 
LDL and HDL (Fig. 5A,B). Slopes of E /M vs. tempera- 
ture lines obtained with PIoPC incorporated in LDL and 
HDL were 0.017 and 0.008 respectively, indicating a 
greater lateral mobility of the probe incorporated in the 
LDL envelope. Slopes of E /M vs. temperature lines ob- 
tained with P~2CS were very similar, being 0.0009 for 
LDL and 0.0008 for HDL, thus indicating a similar lateral 
mobility of P~2CS in the envelope of LDL and HDL. 
Table 1 shows the LDL and HDL lipid composition and 
the vitamin E levels. The percentage of polyunsaturated 
fatty acids in the phospholipids was greater in HDL than in 
LDL: this is mainly due to arachidonic acid (Table 2). The 
association of vitamin E to LDL and HDL, expressed as 
tool vit. E/mol lipoprotein, was 15-fold greater to LDL 
than to HDL; as a function of lipoprotein phospholipids. 
the association to LDL is still significantly greater. 
The effect of copper concentration  the kinetics of the 
oxidation of the core and surface of LDL and HDL was 
studied by measuring the P6Chol and PI2CS fluorescence 
decrease at copper concentrations ranging from 0.5 to 20 
/xM. In all cases increasing the copper concentration led 
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a decrease in lag time and an increase in the velocity of 
propagation; see Fig. 6 for P12CS-labelled HDL. Using the 
approach of Esterbauer and colleagues [36], we plotted the 
data as 1/lag time against copper concentration: the hy- 
perbola function has the mathematical form of the 
Michaelis-Menten equation: 
l / l agt ime = 1/lagtimemi n × [Cu 2+ ] /K  + [Cu 2+ ] 
where lag time min is the theoretical value at infinite 
concentrations of copper. 
This is demonstrated by the fact that data plotted in a 
double reciprocal manner (Figs. 7 and 8) give a strict 
linear equation which can be described: 
lag time = K × lag timemi . × 1 / [  Cu 2+ ] + lag timemi n
Thus two additional parameters are available to describe 
the oxidation of the different domains of lipoproteins: lag 
time min, the minimum latency time theoretically possible 
for oxidation at infinite copper concentration, and K, the 
copper concentration (in /zM) that produces a lag time of 
twice the minimum value. Linear regression analysis 
showed a very high correlation between the experimental 
points. Values obtained from the fluorescence decrease of 
P6Chol, that monitors the oxidation of the hydrophobic 
core of LDL and HDL, were respectively 4.83 and 6.7 
/xM; the corresponding lag time min were 27.3 and 27.4 
min respectively. K-values obtained with P12CS, that moni- 
tors the oxidation of the lipoprotein envelope, were 4.53 
/xM for LDL and 6.58 /zM for HDL; the lag time min 
values were 51.6 and 13.66 min for LDL and HDL 
respectively. 
4. Discussion 
The importance of lipoprotein oxidation phenomena as 
cofactors of different cardiovascular pathologies has been 
stressed in many literature reports (for a review see Ref. 
[37]). The oxidation of LDL and, to a lesser extent, HDL 
has generally been studied considering the whole lipopro- 
tein particle. In this study we evaluated the susceptibility 
of the different lipoprotein regions, i.e., the hydrophobic 
core and the stabilizing envelope, to oxidation by copper 
ions, using pyrene lipids selectively incorporated into the 
different domains of LDL and HDL. The use of pyrene 
derivatives to follow lipid peroxidation is based on our 
previous studies [26] that demonstrated that the fluores- 
cence emission of pyrene incorporated in a lipid environ- 
ment is strongly reduced by iron/ascorbate-induced p r- 
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Fig. 4. Kinetics of lipid peroxidation of LDL (Q) and HDL (• )  followed as TBARS production (panel A) and decrease of fluorescence of PrChol (panel 
(B), PIoPC (panel C) and Pr2CS (panel D). Peroxidation was induced by 10 txM CuSO 4 on 0.1 mg/ml lipoprotein aqueous uspension. 
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Fig. 5. Excimer (475 nm) to monomer (379 nm) ratio (excitation wave- 
length of 343 nm) vs temperature lines of PmPC (panel A) incorporated 
in LDL (0 )  and HDL ( l l )  (r e values: 0.95 and 0.96 respectively) and 
PI2CS (panel B) incorporated in LDL and HDL (r ~ values 0.95 in both 
cases). 
oxidation. In those studies we demonstrated that the de- 
crease in fluorescence is due to an involvement of pyrene 
in the radical reaction that propagates peroxidation. The 
fluorescence of a pyrene derivative incorporated in lipo- 
Table 1 
LDL and HDL composition 
LDL HDL 
Proteins (mg/ml plasma) 0.68 + 0.03 1.1 ± 0.05 
Phospholipids (/xmol/ml plasma) 0.95 + 0.04 1.01 + 0.l 
Cholesterol ( ~mol/ml  plasma) 2.64 + 0.1 1.59 + 0.09 
PUFA/TOT (%) Neutral ipids 7.60 _+ 0.7 10.3 +- 2.2 
Phospholipids 13.3+3.9 18.7+_3.2 
Vit E (mol/mol ipoprotein) 8.1 +_ 1.60 0.53 +_ 0.17 
(nmol//xmol PL) 8.1 _ 0.7 * 5.1 _+ 1.2 
P < 0.02. 
PUFA/TOT, polyunsaturated fatty acids/total fatty acids measurements 
were done in triplicate on five plasma samples; data are means_S.D. 
(n=5). 
Table 2 
Fatty acid profiles of phospho- and neutral ipids in LDL and HDL 
Phospholipids Neutral ipids 
LDL HDL LDL HDL 
16:0 29.1 +3.60 24.4+ 1 .60  15.2___0.47 15.8_+ 1.40 
16:1 1.9+0.50 1.7_+0.40 3.4+0.85 3.1 +0.81 
18:0 14.2+1.1 13.4+0.91 2.9+0.20 4.7+0.26 * * 
18:1 12.0_+0.80 12.3:t=0.97 28.4+ 1.40 25.5+0.53 ~ 
18:2 19.7+ 1.60 21.7+0.65 ~ 40.3+2.80 37.4+3.10 
18:4 1.1 +0.30 0.9_+0.15 0.4-t-0.08 0.7_+0.14 
20:0 1.2+0.40 0.5-4-0.11 1.0_+0.4 1.4+0.4 
20:4 8.4+ 1.40 15.0+ 1.58 * * 6.3+0.87 8.3+2 
20:5 3.3+0.70 2.1 +0.63 ~ 0.5+0.13 0.7+0.t5 
24:0 8.1 + 1.50 7.3-t- 1 .10  1.2_+0.06 1.7__+0.26 
22:6 0.7+0.30 0.7+0.40 0.6_+0.06 0.7_+0.10 
* P < 0.005; * * P < 0.0001. 
Measurements were done in triplicate on 
means + S.D. (n = 5). 
five plasma samples; Data are 
proteins is also reduced in the case of cupric sulfate-depen- 
dent lipid peroxidation (Fig. 4). Also in these experimental 
conditions the pyrene ring seems to be involved in the 
peroxidative reaction, since the fluorescence recorded on 
the lipid extract is also decreased (Fig. 3A), excluding a 
reduction in fluorescence quantum yield due to end prod- 
ucts of lipid peroxidation. Furthermore the absorption 
spectra of pyrene recorded on the lipid extracts after 
peroxidation are strongly modified, indicating that the 
pyrene ring is modified during peroxidation (Fig. 3B). 
The incorporation of different pyrene derivatives in 
LDL and HDL was obtained by incubating whole plasma 
with fluorescent lipids; we used this procedure in order to 
minimize the possibility of oxidative processes during the 
incubation period. The different lipoprotein classes were 
then separated by ultracentrifugation a d analyzed for 
protein, phospholipid and total cholesterol content (Table 
1). Considering the chemical structure of fluorescent lipids 
and their distribution in the different lipoprotein fractions 
100 
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Fig. 6. Effect of copper concentration  the peroxidation kinetics of the 
HDL envelope measured as PI2CS fluorescence decrease: 0.5 (v) ,  1 
(O), 2 (A), 3 (-k), 5 (11) and 10 (0 )  /~M CuSO 4. 
84 P. Viani et al. / Biochimica et Biophysica Acta 1315 (1996) 78-86 
250 
200 
150 
100 
50 
I I 1 I I 
-0,2 0 0,2 0,4 0,6 0,8 1 
I/[C'~SO,] 
Fig. 7. Plots of lag time vs 1/[CuSO4] determined in the hydrophobic 
core of LDL (0 )  and HDL (11) by measuring the kinetics of fluores- 
cence decrease of P6Chol at CuSO 4 concentration ranging from 1 /xM to 
20 /zM; r 2 LDL = 0.99, HDL = 0.98. 
(Fig. 1), it can be assumed that the fluorescent derivative 
of cholesteryl ester P6Chol is incorporated in the hy- 
drophobic core of LDL and HDL with a preferential 
location in LDL; the fluorescent derivative of phospha- 
tidylcholine, P10PC, is almost equally distributed between 
the phospholipid envelope of LDL and HDL; the fluores- 
cent derivative of sulfatide P12CS is incorporated in the 
envelope of lipoprotein with a preferential location in the 
HDL envelope. Thus Pt0PC, P12CS and P6Chol were used 
to selectively monitor the kinetics of lipid peroxidation i
the envelope and the core of LDL and HDL. 
The response of hydrophobic core to an oxidative stress 
induced by 10 /zM CuSO 4 is very similar in LDL and 
HDL, considering both the resistance to and the rate of 
peroxidation (Fig. 4B). On the contrary, the envelope of 
800 
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Fig. 8. Plots of Lag time vs 1/[CuSO 4] in the envelope of LDL (0 )  at 
CuSO 4 concentration ranging from 1 to 20 /xM and in the envelope of 
HDL (11) at CuSO 4 concentrations ranging from 0.5 to 10 /xM deter- 
mined by measuring the kinetics of fluorescence decrease of PI2CS; r 2 
LDL = 0.95, HDL = 0.98. 
HDL is more rapidly peroxidized than that of LDL (Fig. 
4C,D). In particular the latency time, which is an index of 
the antioxidant capacity of lipoprotein, is 3-fold shorter in 
HDL than in LDL; similarly, the rate of peroxidation i  
HDL is about 3-fold greater than in LDL. This evidence 
was confirmed by the use of two different amphipatic 
probes P10PC and P12CS. 
The higher oxidability of the HDL envelope could 
depend on several factors, including the frequency of 
radical collisions due to the fluidity of the lipid environ- 
ment, the levels of peroxidable substrates, the concentra- 
tion of antioxidants and a different catalyzing capacity of 
copper in the two lipoprotein classes. 
In a recent study, Barenholz and colleagues [38] re- 
ported that the fluidity of the LDL envelope is greater than 
that of HDL, primarily as a consequence of a smaller 
protein to lipid ratio; in addition, the E /M vs. temperature 
lines obtained with PloPC and P1zCS incorporated in HDL 
and LDL indicate, respectively, a greater and equal lateral 
mobility of pyrene lipids in the envelopes of LDL and 
HDL (Fig. 5). Thus the differences observed in the kinetics 
of lipid peroxidation cannot be ascribed to a greater fre- 
quency of collisions, neither between lipid radicals nor 
between lipids and pyrene derivatives. 
The fatty acid profiles of phospholipids showed that the 
amount of polyunsaturated fatty acids, namely arachidonic 
acid, is higher in HDL than LDL (Table 2). Nevertheless, 
this difference is not sufficient to explain the different 
reactivity observed in the kinetics of lipid peroxidation. On 
the contrary, if we consider the levels of vitamin E, the 
quantitatively most important antioxidant present in 
lipoprotein, LDL is more protected than HDL; in fact 
moles of vitamin E associated to one mole of LDL are 
15-fold that associated to one mole of HDL (Table 1). On 
the basis of its chemical structure, vitamin E is probably 
inserted in the phospholipid monolayer of lipoprotein [39], 
therefore it could be better to express the vitamin E 
concentrations a  a function of lipoprotein phospholipid 
content. The vitamin E/phospholipid ratio is significantly 
lower in HDL than in LDL (Table 1); this could play an 
important role in the observed higher oxidability of the 
HDL envelope. 
The existence of a finite number of copper binding 
sites, that can initiate lipid peroxidation in LDL, has 
recently been demonstrated by Esterbauer and colleagues 
[36]; we applied the approach described by these authors to 
evaluate the binding copper capacity of LDL and HDL. To 
calculate the copper concentration, i  which half the LDL 
and HDL prooxidative binding sites are occupied, we used 
lag times determined at different copper concentrations in 
the envelope (Fig. 8) and core (Fig. 7) of both lipoproteins. 
As expected the calculated prooxidant copper binding sites 
within LDL and HDL did not depend on the probe used to 
follow lipid peroxidation, and LDL showed a greater affin- 
ity for oxidizing copper (K = 4.83 /~M and K = 4.53 /xM 
determined with P6Chol and P IzCS  respectively) than did 
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HDL (K = 6.7 /zM and K = 6.58 p,M determined with 
P6Chol and PI2 respectively). On the contrary, calculated 
lag time rain, which is inversely correlated to the radical 
generating capacity [36], is very similar when it is calcu- 
lated for the hydrophobic ore of LDL and HDL (23.7 and 
27.4 min respectively), but dramatically different when 
calculated for the envelope of the two lipoproteins. In fact 
lag time m~n calculated for LDL (51.6 min) is about 4-fold 
that calculated for HDL (13.66 min). Thus the radical 
generating capacity of copper bound to HDL is about 
4-fold that of copper bound to LDL. As mentioned above, 
HDL, if compared with LDL, is characterized by lower 
concentrations of vitamin E which is preferentially ocated 
in the lipoprotein envelope, and higher amounts of poly- 
unsaturated fatty acids esterified to phospholipids; in addi- 
tion, Bowry and colleagues [12] demonstrated that HDL is 
the principal vehicle for circulating plasma lipid hydro- 
peroxides. Taken together, these observations could ex- 
plain the higher radical generating capacity associated to 
the envelope of HDL. 
In our experimental conditions LDL and HDL were 10- 
and 20-fold diluted with respect o their plasma concentra- 
tions; the physiological copper concentrations were about 
10 /xM, this being associated to ceruloplasmin, thus a 10- 
and 20-fold dilution of copper corresponds to ! /xM and 
0.5 /xM respectively. Comparing the kinetics of LDL and 
HDL peroxidation (Fig. 8) obtained with 1 and 0.5 /xM 
CuSO 4 respectively, the resistance to oxidation of ti~e 
HDL envelope (186 min) is 2-fold less than that of LDL 
(300 rain). Ceruloplasmin at physiological concentrations 
can release, or express, enough copper ions to catalyze 
lipoprotein oxidation if exposed at moderately acid pH 
[40]. Although there is no experimental evidence for this, 
an acidic condition could theoretically occur within the 
atherosclerotic lesion, since the media of large arteries is 
paradoxically one of the most poorly perfused tissues in 
human body and hence experiences a low oxygen tension 
[41] which may result in a local acidosis. In addition, 
atherosclerosis i  often described as a chronic inflamma- 
tory disease, and by analogy to other inflammatory sites, 
the pH could be expected to fall below pH 7.4. If low pH 
values were present within the atherosclerotic lesions, the 
HDL envelope could constitute the first target of the 
Cu-mediated peroxidative damage. 
In conclusion, the modifications of the envelope of 
HDL consequent to oxidative stress could be important in 
the altered reverse cholesterol transport observed with 
oxidized HDL [23], and provide early markers for monitor- 
ing the initial stages of the oxidative imbalance that could 
be involved in the development of atherosclerotic lesions. 
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